| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement M Dominici, K Le Blanc, I Mueller, I Slaper-Cortenbach, FC Marini, ... Cytotherapy 8 (4), 315-317, 2006 | 20841 | 2006 |
| Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the … C Théry, KW Witwer, E Aikawa, MJ Alcaraz, JD Anderson, ... Journal of extracellular vesicles 7 (1), 1535750, 2018 | 8262 | 2018 |
| Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement EM Horwitz, K Le Blanc, M Dominici, I Mueller, I Slaper-Cortenbach, ... Cytotherapy 7 (5), 393-395, 2005 | 2496 | 2005 |
| Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International … P Bourin, BA Bunnell, L Casteilla, M Dominici, AJ Katz, KL March, H Redl, ... Cytotherapy 15 (6), 641-648, 2013 | 2044 | 2013 |
| International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials J Galipeau, M Krampera, J Barrett, F Dazzi, RJ Deans, J DeBruijn, ... Cytotherapy 18 (2), 151-159, 2016 | 487 | 2016 |
| Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications KW Witwer, BWM Van Balkom, S Bruno, A Choo, M Dominici, M Gimona, ... Journal of extracellular vesicles 8 (1), 1609206, 2019 | 454 | 2019 |
| International Society for Cellular Therapy. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement EM Horwitz, K Le Blanc, M Dominici, I Mueller, I Slaper-Cortenbach, ... Cytotherapy 7 (5), 393-395, 2005 | 415 | 2005 |
| Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs C Martinez, TJ Hofmann, R Marino, M Dominici, EM Horwitz Blood 109 (10), 4245-4248, 2007 | 363 | 2007 |
| Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells F Gieseke, J Böhringer, R Bussolari, M Dominici, R Handgretinger, ... Blood, The Journal of the American Society of Hematology 116 (19), 3770-3779, 2010 | 326 | 2010 |
| Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM I Müller, S Kordowich, C Holzwarth, C Spano, G Isensee, A Staiber, ... Cytotherapy 8 (5), 437-444, 2006 | 315 | 2006 |
| Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor–related apoptosis-inducing ligand delivery for cancer therapy G Grisendi, R Bussolari, L Cafarelli, I Petak, V Rasini, E Veronesi, ... Cancer research 70 (9), 3718-3729, 2010 | 311 | 2010 |
| Rare breast cancer subtypes: histological, molecular, and clinical peculiarities MV Dieci, E Orvieto, M Dominici, PF Conte, V Guarneri The oncologist 19 (8), 805-813, 2014 | 248 | 2014 |
| Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation I Müller, S Kordowich, C Holzwarth, G Isensee, P Lang, F Neunhoeffer, ... Blood Cells, Molecules, and Diseases 40 (1), 25-32, 2008 | 231 | 2008 |
| Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation M Dominici, V Rasini, R Bussolari, X Chen, TJ Hofmann, C Spano, ... Blood, The Journal of the American Society of Hematology 114 (11), 2333-2343, 2009 | 224 | 2009 |
| Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-institution analysis MV Dieci, E Barbieri, F Piacentini, G Ficarra, S Bettelli, M Dominici, ... Annals of oncology 24 (1), 101-108, 2013 | 216 | 2013 |
| Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation M Dominici, C Pritchard, JE Garlits, TJ Hofmann, DA Persons, EM Horwitz Proceedings of the National Academy of Sciences 101 (32), 11761-11766, 2004 | 215 | 2004 |
| Challenges in clinical development of mesenchymal stromal/stem cells: concise review I Mastrolia, EM Foppiani, A Murgia, O Candini, AV Samarelli, G Grisendi, ... Stem cells translational medicine 8 (11), 1135-1148, 2019 | 206 | 2019 |
| How do mesenchymal stromal cells exert their therapeutic benefit? EM Horwitz, M Dominici Cytotherapy 10 (8), 771-774, 2008 | 186 | 2008 |
| Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase K Mihara, C Imai, E Coustan‐Smith, JS Dome, M Dominici, E Vanin, ... British journal of haematology 120 (5), 846-849, 2003 | 179 | 2003 |
| Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies N D’souza, F Rossignoli, G Golinelli, G Grisendi, C Spano, O Candini, ... BMC medicine 13, 1-15, 2015 | 170 | 2015 |
